Credo Technology (CRDO) director Sutardja sells 1,875 shares in 10b5-1 trade
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Credo Technology Group Holding Ltd director share sale under 10b5-1 plan
Director Pantas Sutardja reported selling 1,875 Ordinary Shares of Credo Technology Group Holding Ltd on January 30, 2026 at $128.67 per share. After this trade, he beneficially owned 5,892,034 Ordinary Shares, held directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 26, 2025, which allows systematic transactions set up in advance.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,875 shares ($241,256)
Net Sell
1 txn
Insider
Sutardja, Pantas
Role
Director
Sold
1,875 shs ($241K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 1,875 | $128.67 | $241K |
Holdings After Transaction:
Ordinary Shares — 5,892,034 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Credo Technology (CRDO) director Pantas Sutardja report in this Form 4?
Pantas Sutardja reported selling 1,875 Ordinary Shares of Credo Technology at $128.67 per share. The transaction occurred on January 30, 2026, and was reported as a direct ownership sale, leaving him with 5,892,034 Ordinary Shares beneficially owned.
Was the Credo Technology (CRDO) Form 4 sale part of a Rule 10b5-1 trading plan?
Yes, the sale was executed under a Rule 10b5-1 trading plan. The footnote explains that the transactions were effected pursuant to a trading plan adopted by the reporting person on June 26, 2025, allowing pre-arranged, systematic share sales.
What is the role of the reporting person in Credo Technology (CRDO)?
The reporting person, Pantas Sutardja, is a director of Credo Technology Group Holding Ltd. The Form 4 identifies his relationship to the issuer as a director, with the director box checked and no officer or 10% owner status indicated.
Does this Credo Technology (CRDO) Form 4 include any derivative securities transactions?
No derivative securities transactions are reported in this Form 4. The derivative securities table is present but contains no entries, indicating that only non-derivative Ordinary Shares were involved in the disclosed transaction on January 30, 2026.